Raf inhibitor Regorafenib monohydrate, Purity ≥98%

Synonym: 1019206-88-2; Regorafenib monohydrate; Regorafenib hydrate; Regorafenib (monohydrate); Regorafenib hydrate [JAN]; BAY 73-4506 monohydrate; 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate; Raf inhibitor

MDL: MFCD17170366
CAS Number: 1019206-88-2
Compound CID: 24768591

Product Size

50 mg; 100 mg; 200 mg; 500 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Regorafenib monohydrate, soluble in DMSO and ethanol, blocks a MAPK/ERK signaling pathway.

Molecular Weight

500.83

Molecular Formula

C₂₁H₁₇ClF₄N₄O₄

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 93 mg/mL (185.68 mM); Ethanol: <1 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

Regorafenib monohydrate can be studied for its effects on targeting multiple kinases involved in tumor growth and angiogenesis.